An eye drop that treats glaucoma while you sleep has been developed by scientists.
It is based on a chemical found in cannabis and could end the misery of twice daily drops that are often ineffective.
“Less than 5 per cent of the drug stays in the eye because most of the drops just roll off the eye.
“Even when the drug is absorbed it may fail to reach the back of the eye where it can start repairing damaged neurons and relieving the pressure that characterises glaucoma.”
To solve these problems his team created a watery gel – or hydrogel. This was then filled with thousands of nanoparticles containing a chemical called CBGA (cannabigerolic acid). It is found in the marijuana plant and has already shown promise in relieving symptoms of glaucoma.
The disorder blights the lives of more than 56,00 people in Scotland. Many more may not know they have the condition.
When the researchers applied their drops on donated pig corneas similar to human corneas – they were absorbed quickly and reached the back of the eye.
The team whose gel is described in the journal Drug Delivery & Translational Research is now working to scale up production and develop more anti-glaucoma cannabinoid molecules using genetically engineered microbes. Glaucoma is caused by the death of cells in the retina at the back of the eye.
A spokesperson for sight loss charity RNIB Scotland said any new developments that improve on the treatment are welcome, but urged people to get a regular eye examination – free in Scotland.
“An eye test is the only way to detect glaucoma in its early stages so it’s vital that everyone does attend for an eye check-up at least every two years.”